Wang et al. (2020) cultured cells from patients with relapsed/refractory ALL with MSCs, which resulted in a higher expression of CXCR4 and CXCL12 in the presence of the chemotherapeutic agent vincristine. The gene discussed is CXCR4; the disease is acute lymphoblastic leukemia.